Table 4.
Comparison of the levels of FGF21 and FGF23 between controls and patients before and after treatment, including PASI-scoring. FGF21 and FGF23 concentrations given in pg/mL.
| Controls | Study Group | PASI I | PASI II | PASI III | |
|---|---|---|---|---|---|
| FGF 21 | |||||
| Before | 4.75 (0.42–63.9) | 19.9 (0.42–1993) * | 14.7 (3.02–90.8) * # | 7.49 (0.42–63.9) * # | 34.9 (3.02–1993) * # |
| After | 12 (2–11507) * | 14.5 (2–11507) * | 8.49 (2–43.6) * | 13.6 (3–2493) * | |
| FGF 23 | |||||
| After | 1.32 (0.06–7.38) | 1.85 (0.06–10.4) | 2.03 (0.12–7.72) | 1.43 (0.19–10.4) | 1.85 (0.06–5.74) |
| Before | 1.97 (0.19–8.06) | 3.49 (0.19–8.06) | 1.78 (0.34–6.38) | 1.85 (0.89–6.71) |
* statistical significances with p < 0.05 between Controls and Patients groups. # statistical significances with p < 0.05 between BMI-subgroups.